Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NiTraSarc: Nivolumab and Trabectedin in Advanced Soft Tissue Sarcomas
NCT03590210Phase 2Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Jun 2018
- Primary completion
- Feb 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in soft tissue sarcoma (STS), sponsored by Universitätsklinikum Greifswald. Started Jun 2018; status: completed.
02
Drugs
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03590210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590210.